CMND
Clearmind Medicine
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 0
ample liquidity
RSI Oversold
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About CMND
Clearmind Medicine Inc.
A pharmaceutical company developing a new psychedelic drug
Life Science Tools and Services
07/18/2017
11/15/2022
NASDAQ Stock Exchange
3
10-31
Common stock
101–1220 West 6th Avenue, Vancouver, British Columbia V6H1A5
--
Clearmind Medicine Inc., was incorporated in British Columbia on July 18, 2017. They are a preclinical pharmaceutical company approaching a phase 1 clinical trial, developing new psychedelic drugs to address a widespread but underserved health problem. Their goal is to develop and offer a new type of treatment for AUD, including binge eating disorder, where there is a large unmet need and lack of innovation.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
